| __timestamp | Alpine Immune Sciences, Inc. | Apellis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2287709 | 2908166 |
| Thursday, January 1, 2015 | 6844000 | 6356782 |
| Friday, January 1, 2016 | 8586000 | 4303743 |
| Sunday, January 1, 2017 | 6079000 | 10463151 |
| Monday, January 1, 2018 | 8362000 | 22639184 |
| Tuesday, January 1, 2019 | 9467000 | 67046483 |
| Wednesday, January 1, 2020 | 10899000 | 139401000 |
| Friday, January 1, 2021 | 14560000 | 176771000 |
| Saturday, January 1, 2022 | 17968000 | 277163000 |
| Sunday, January 1, 2023 | 22222000 | 500815000 |
Unleashing the power of data
In the dynamic world of biotechnology, effective cost management is crucial for sustaining innovation and growth. Over the past decade, Alpine Immune Sciences, Inc. and Apellis Pharmaceuticals, Inc. have demonstrated contrasting trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Alpine Immune Sciences saw a steady increase in SG&A expenses, peaking at approximately $22 million in 2023, marking a tenfold rise from 2014. Meanwhile, Apellis Pharmaceuticals experienced a staggering growth, with expenses soaring from around $3 million in 2014 to over $500 million in 2023, a remarkable 170-fold increase. This divergence highlights the varying strategies and scales of operation between these two companies. As investors and stakeholders analyze these trends, understanding the underlying factors driving these expenses becomes essential for making informed decisions in the biotech sector.
Novartis AG and Alpine Immune Sciences, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Pfizer Inc. vs Alpine Immune Sciences, Inc.
SG&A Efficiency Analysis: Comparing GSK plc and Alpine Immune Sciences, Inc.
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Alpine Immune Sciences, Inc.
Breaking Down SG&A Expenses: Pharming Group N.V. vs Apellis Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? TG Therapeutics, Inc. or Apellis Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Alpine Immune Sciences, Inc. or Ligand Pharmaceuticals Incorporated
Operational Costs Compared: SG&A Analysis of Alpine Immune Sciences, Inc. and Soleno Therapeutics, Inc.
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Apellis Pharmaceuticals, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Apellis Pharmaceuticals, Inc. and Perrigo Company plc
SG&A Efficiency Analysis: Comparing Apellis Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Apellis Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.: SG&A Spending Patterns Compared